Simply Wall St.85d agoneutral
Is Iovance Biotherapeutics (IOVA) Undervalued As Q2 Earnings Reaffirm Revenue Guidance?News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
Barrons.com93d agobullish
Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling.GuruFocus.com94d agoneutral
Iovance Biotherapeutics Inc (IOVA) (Q2 2026) Earnings Call Highlights: Record Revenue and ...Insider Monkey94d agoneutral
Iovance Biotherapeutics (IOVA) Pops 43% on Stellar Q2. Here’s What Comes NextStocktwits94d agobullish
IOVA Stock Heads For Best Day In Over 6 Years - Buyout Buzz Builds After Blowout Q2InvestorsHub94d agoneutral
Iovance Biotherapeutics Reports Record Q2 Revenue and Reviews 2026 Outlook on Strong Amtagvi DemandSimply Wall St.98d agoneutral
Iovance Biotherapeutics (IOVA) Stock May Be Cheap As Sales Ramp Remains KeySimply Wall St.99d agoneutral
Do Mixed Q2 Expectations Alter Iovance Biotherapeutics' (IOVA) TIL Leadership Narrative?Simply Wall St.99d agoneutral
Iovance Biotherapeutics (IOVA) Heads Into Earnings With Its T Cell Therapy Story And Valuation In FocusInsider Monkey122d agoneutral
Iovance Biotherapeutics (IOVA) Updates its Corporate Presentation, Here’s What’s Important to NoteMotley Fool127d agobullish
Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool138d agobullish
Amgen vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?Insider Monkey148d agobullish
Amtagvi Approval Boosted Iovance Biotherapeutics, Inc. (IOVA), But Can the Rally Last?Insider Monkey151d agoneutral
Iovance Biotherapeutics (IOVA) Advances Next-Generation TIL Pipeline With FDA Clearance for IOV-5001Insider Monkey154d agobullish
Iovance Biotherapeutics, Inc. (IOVA) a Top Penny Stock to Buy on Amtagvi Strong Adoption